A Study of IBI362 in Chinese Adolescents With Obesity or Overweight — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study of IBI362 in Chinese Adolescents With Obesity or Overweight — Stella

Home/Adolescents With Obesity or Overweight With Weight-Related Comorbidities/

View on ClinicalTrials.gov

Recruiting

Back to Adolescents With Obesity or Overweight With Weight-Related Comorbidities trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

China

The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang

Key details

Phase

Large-scale testing

Sponsor

Innovent Biologics (Suzhou) Co. Ltd.

Enrollment target

~180 participants

Started

December 2025

Primary completion

October 2027

Age range

12 Years – 18 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.